Jaeger, Natalia
Gamini, Ramya http://orcid.org/0000-0002-9205-9792
Cella, Marina http://orcid.org/0000-0003-1230-1313
Schettini, Jorge L. http://orcid.org/0000-0002-3089-7918
Bugatti, Mattia
Zhao, Shanrong
Rosadini, Charles V.
Esaulova, Ekaterina http://orcid.org/0000-0001-9806-662X
Di Luccia, Blanda
Kinnett, Baylee
Vermi, William http://orcid.org/0000-0002-2291-2997
Artyomov, Maxim N. http://orcid.org/0000-0002-1133-4212
Wynn, Thomas A.
Xavier, Ramnik J. http://orcid.org/0000-0002-5630-5167
Jelinsky, Scott A. http://orcid.org/0000-0002-5114-0236
Colonna, Marco http://orcid.org/0000-0001-5222-4987
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (UO1 AI095542, U19 AI142733)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 30 October 2020
Accepted: 3 March 2021
First Online: 26 March 2021
Competing interests
: R.G., S.Z., J.S., C.V.R., T.A.W., and S.A.J. are Pfizer employees. M.Co. received funding from Pfizer to study ILC biology in Inflammatory Bowel Disease. The remaining authors declare no competing interests.